BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC.
Iqbal J, et al. Among authors: vose jm.
J Clin Oncol. 2006 Feb 20;24(6):961-8. doi: 10.1200/JCO.2005.03.4264. Epub 2006 Jan 17.
J Clin Oncol. 2006.
PMID: 16418494